| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.039 | 0.4 |